aod9604 dosage protocol AOD-9604 Chart – 2 mg Vial AOD‑9604 Peptide for Fat Loss:

The primary outcomeweight losswas negative: the AOD-9604 treatment groups demonstrated no statistically significant reduction in body weight compared to placebo

The trials tested oral, intravenous, and subcutaneous routes of administration at doses ranging from micrograms to 1 mg per day

Researchers wanted to isolate just the fat-burning signal and AOD-9604 was the result

Stacking with other peptides targeting different mechanisms (such as GH secretagogues that work through the GHRH axis rather than direct fat-cell signalling) is theoretically additive

At SynergenX, we offer B-12 in the form of a Methylcobalamin injection